Supernus Pharmaceuticals, Inc. (SUPN)
43.29
-0.10
(-0.23%)
USD |
NASDAQ |
Sep 24, 16:00
43.29
0.00 (0.00%)
After-Hours: 19:59
Supernus Pharmaceuticals Gross Profit (Annual) : 552.83M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 552.83M |
| December 31, 2024 | 503.50M |
| December 31, 2023 | 438.88M |
| December 31, 2022 | 494.39M |
| December 31, 2021 | 472.12M |
| December 31, 2020 | 447.94M |
| December 31, 2019 | 376.10M |
| December 31, 2018 | 393.54M |
| December 31, 2017 | 287.02M |
| December 31, 2016 | 203.02M |
| Date | Value |
|---|---|
| December 31, 2015 | 139.04M |
| December 31, 2014 | 116.29M |
| December 31, 2013 | 10.92M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.016B |
| Prestige Consumer Healthcare, Inc. | 574.64M |
| Pfizer Inc. | 41.04B |
| Amphastar Pharmaceuticals, Inc. | 341.45M |
| Bristol Myers Squibb Co. | 31.76B |